Local Anesthesia Drugs Market Growth & Trends
The global local anesthesia drugs market size is anticipated to reach USD 5.14 billion in 2030 and is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising number of surgical procedures across the globe, including cosmetic surgeries, dental procedures, and plastic surgeries, is driving the growth of local anesthetics.
There has been a considerable increase in the number of surgical procedures requiring post-operative pain relief and this trend is expected to continue throughout the forecast period. Roughly, 65.0% of total surgical procedures require post-operative pain management. This is likely to boost the demand for local anesthesia drugs.
The introduction of new and effective drugs such as levobupivacaine, articaine, and ropivacaine is also driving the growth of the local anesthesia drugs market across the globe. Rising healthcare expenditure in developing countries is expected to result in an increase in the number of surgeries performed in countries such as India, China, and Brazil. This is likely to contribute to market growth in the region.
Local Anesthesia Drugs Market Report Highlights
- Lidocaine dominated the market by product as of 2016 owing to its extensive use as a topical and injectable anesthetic
- By application, the market is bifurcated into injectable and surface anesthetic. The injectable segment is expected to dominate the local anesthesia drugs market during the forecast period owing to extensive usage in different surgical procedures. Advancements in drug delivery systems are expected to drive the market for surface anesthetics over the forecast period
- North America held the largest share in the market for local anesthesia drugs owing to a significant number of surgical procedures performed in the region
- Some of the key players are Aspen Pharmacare; Fresenius Kabi; Novartis, Inc.; Sagent Pharmaceutical; Pacira Pharmaceutical; Mylan; and Teva Pharmaceuticals.
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Local Anesthesia Drugs Market Variables, Trends, & Scope
Chapter 4. Local Anesthesia Drugs Market: Drug Estimates & Trend Analysis
Chapter 5. Local Anesthesia Drugs Market: Application Estimates & Trend Analysis
Chapter 6. Local Anesthesia Drugs Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Johnson & Johnson Services, Inc
- Pfizer Inc.
- AstraZeneca plc
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- GlaxoSmithKline plc
- Sanofi S.A.
- Merck & Co., Inc.
- Aspen Pharmacare Holdings Limited
- Mylan N.V.
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 100 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 4.01 Billion |
| Forecasted Market Value ( USD | $ 5.14 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
